Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Medical and Pediatric Oncology|January 1, 1990
Treatment of metastatic malignant melanoma with trimetrexate: a phase II studyO Odujinrin, D Goldberg, J Doroshow, et al.
Medical Oncology (Northwood, London, England)|March 29, 2002
Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokinesJ Dutcher, M B Atkins, K Margolin, et al.
Medical Oncology (Northwood, London, England)|March 29, 2002
Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trialsM B Atkins, J Dutcher, G Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety dataK Margolin, M S Gordon, E Holmgren, et al.
Investigational New Drugs|February 1, 1991
Phase II study of 4'-deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomachG Somlo, J Doroshow, S Akman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancerM S Gordon, K Margolin, M Talpaz, et al.
Investigational New Drugs|November 1, 1990
3-Deazaguanine: report of a phase I trial and drug-related cardiac toxicityK Margolin, J Doroshow, L Leong, et al.
Cancer Investigation|January 1, 1995
5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trialM Tetef, J Doroshow, S Akman, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trialM Tetef, K Margolin, C Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calciumJ H Doroshow, L Leong, K Margolin, et al.
Pageof 7